Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TORSEMIDE USP, with a corresponding US DMF Number 23760.
Remarkably, this DMF maintains an Active status since its submission on September 15, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 24, 2014, and payment made on August 08, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II